Essential Health Benefits Standard Specialty PA and QL List July 2016

Similar documents
Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

MedStar Medicare Choice Pharmacy Services

List of Designated High-Cost Drugs

SPECIALTY PHARMACY Master Clinical Drug List

Aetna Better Health. Specialty Drug Program

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

Specialty Drugs. The specialty drug list below is effective June 5, 2018 and is subject to change at any time.

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

Genetics in Cancer Therapy. Raju Kucherlapati, Ph.D. Harvard Medical School

2017 MDwise HIP Medical Services that Require Prior Authorization

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

Specialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

LIMITED DISTRIBUTION MEDICATIONS

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

acromegaly Drugs Covered Uses Exclusion Criteria Required Medical Information Age Restriction Prescriber Restriction Coverage Duration

DRUGS REQUIRING PRIOR AUTHORIZATION

2016 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization

Injections Requiring Prior Authorization

OPENING KEYNOTE: PRECISION MEDICINE AT THE INFLECTION POINT. Session PM1, March 5, 2018 Damon Hostin, CEO, Precision Medicine Alliance, LLC

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3*

Lista de medicamentos especializados

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

Drug Name Generic Name J-Code Unclassified Drugs in excess of $10,000

Original Policy Date

SELF-ADMINISTERED MEDICATIONS LIST

2016 MDwise HIP Medical Services that Require Prior Authorization

MDwise Hoosier Care Connect Medical Services that Require Prior Authorization

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions

Pharmacy and Medical Guideline Updates

SUPPLEMENTARY INFORMATION

MEDICAL NECESSITY GUIDELINE

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3*

Overview of Cancer. Laura Bingell RN Transition Center Nurse for MFP (607)

BCN Advantage SM requirements for drugs covered under the medical benefit

Prescription Drug Benefit Rider V

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Prescription Drug Benefit Rider

MDwise HIP Prior Authorization and Drug List

Chemotherapy 101 for Radiation Oncology Workers

Criteria for Medical Benefit Drugs Requiring Clinical Review

Premium prior authorization

ORAL ONCOLOGY CRITERIA

after reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related

Clinical UM Guidelines for Indiana, Kentucky, Missouri, Ohio and Wisconsin

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

Criteria for Medical Benefit Drugs Requiring Clinical Review

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

Injectable Drugs Requiring Pre-Service Approval

Re: Integrated Oncology Management Program with evicore healthcare: Update on codes requiring precertification

ORAL ONCOLOGY CRITERIA

Select Prior Authorization

ACAMPROSATE (CAMPRAL)

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

Medical Prior Authorization List Rosen Employee Plans For prescription drug requirements, contact EHIM toll-free at

State: Virginia. Clinical Guidelines Applicable for Virginia

Select Prior Authorization

Special Notes Implementation Date by CO. State CG number CG title CG Category Original Current Version

Specialty Pipeline Update

Pharmacy Medical Necessity Guidelines: Oral Cancer Medications

Utilization Management

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class

J-Code Trade Name Drug Name Required Medical Information

Buckeye Health Plan (MMP) 2016 Prior Authorization Criteria

Specialty Pipeline Update

Specialty Pipeline Update

Select Prior Authorization

ALPHA1-PROTEINASE INHIBITOR

CPT Service Description Effective Date

FIDELIS CARE NEW YORK DEPARTMENT OF PHARMACY SERVICES J Code Prior Authorizations & Required Clinical Information 2011 (Updated 3/14/11)

Pharmacy Policy Bulletin

LDI integrated pharmacy services

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ORAL ONCOLOGY CRITERIA LENGTH OF AUTHORIZATION: Varies; Maximum of one year

Prior Authorization Program

Pharmacy Services Request Types

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY]

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

Specialty Overview by Prior Authorization Approval or Denial 4th Quarter 2016

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

Specialty Overview by Prior Authorization Approval or Denial 2nd Quarter 2016

Transcription:

Anti-infectives Antiretrovirals, HIV SELZENTRY (maraviroc) Cardiology Antilipemic Pulmonary Arterial Hypertension Central Nervous System Anticonvulsants Depressant Neurotoxins Parkinson's Sleep Disorder Dermatology JUXTAPID (lomitapide) PRALUENT (alirocumab) REPATHA (evolocumab) ADCIRCA (tadalafil) ADEMPAS (riociguat) FLOLAN (epoprostenol) LETAIRIS (ambrisentan) OPSUMIT (macitentan) ORENITRAM (treprostinil diolamine) REMODULIN (treprostinil) REVATIO (sildenafil) Soln REVATIO (sildenafil) Tabs TRACLEER (bosentan) TYVASO (treprostinil) UPTRAVI (selexipag) UPTRAVI (selexipag) Pack VELETRI (epoprostenol) VENTAVIS (iloprost) SABRIL (vigabatrin) pack XYREM (sodium oxybate) BOTOX (onabotulinumtoxina) DYSPORT (abobotulinumtoxina) MYOBLOC (rimabotulinumtoxinb) XEOMIN (incobotulinumtoxina) APOKYN (apomorphine) HETLIOZ (tasimelteon) Alkylating Agents VALCHLOR (mechlorethamine) Gel Electrolyte & Renal Agents 2 syringes/28 days 3 syringes/28 days 3 tabs/day Updated 07/01/2016 Page 1 of 6 3 tabs/day 1 ampule/day 2 packs/year 9 ampules/day 3 bottles (540 ml)/30 days 20 cartridges/30 days 1 cap/day Diuretics KEVEYIS (dichlorphenamide) 4 tabs/day Endocrinology & Metabolism Gonadotropins ELIGARD (leuprolide) 22.5 mg (3-month) 1 injection/84 days ELIGARD (leuprolide) 30 mg (4-month) ELIGARD (leuprolide) 45 mg (6-month) ELIGARD (leuprolide) 7.5 mg (1-month) FIRMAGON (degarelix) 120 mg FIRMAGON (degarelix) 80 mg LUPRON (leuprolide) 1 mg/0.2 ml LUPRON DEPOT (leuprolide) 3.75 mg & 7.5 mg (1-month) LUPRON DEPOT-PED (leuprolide) SUPPRELIN LA (histrelin acetate) 1 injection/112 days 1 injection/168 days 1 injection/28 days 2 vials/year 1 vial/28 days 1 kit/365 days

Endocrinology & Metabolism Gonadotropins Growth Hormones and Related Therapy Hormone Modifiers Osteoporosis Somatostatins Enzyme-Related Alpha-1 proteinase inhibitor Cystine-depleting Agents Enzyme Replacement Enzyme, Gout Phenylketonuria Treatment Agents Gastroenterology TRELSTAR (triptorelin) 22.5 mg (6-month) TRELSTAR DEPOT (triptorelin) 3.75 mg (1-month) TRELSTAR LA (triptorelin) 11.25 mg (3-month) VANTAS (histrelin) EGRIFTA (tesamorelin) 1 mg EGRIFTA (tesamorelin) 2 mg NORDITROPIN (somatropin) NUTROPIN (somatropin) NUTROPIN AQ (somatropin) SEROSTIM (somatropin) ZORBTIVE (somatropin) INCRELEX (mecasermin) SOMAVERT (pegvisomant) MYALEPT (metreleptin) H.P. ACTHAR (corticotropin) PROLIA (denosumab) SANDOSTATIN (octreotide) SANDOSTATIN LAR (octreotide) SIGNIFOR (pasireotide) SOMATULINE DEPOT (lanreotide) ARALAST (alpha-1 proteinase inhibitor) GLASSIA (alpha-1 proteinase inhibitor) PROLASTIN (alpha-1 proteinase inhibitor) ZEMAIRA (alpha-1 proteinase inhibitor) CYSTARAN (cysteamine) PROCYSBI (cysteamine bitartrate) ALDURAZYME (laronidase) CEREZYME (imiglucerase) ELAPRASE (idursulfase) ELELYSO (taliglucerase) FABRAZYME (agalsidase beta) KANUMA (sebelipase alfa) LUMIZYME (alglucosidase alfa) MYOZYME (alglucosidase alfa) NAGLAZYME (galsulfase) RAVICTI (glycerol phenylbutyrate) STRENSIQ (asfotase alfa) VIMIZIM (elosulfase) VPRIV (velaglucerase) ZAVESCA (miglustat) KRYSTEXXA (pegloticase) KUVAN (sapropterin) Short Bowel Syndrome GATTEX (teduglutide) 1 injection/168 days 1 injection/28 days 1 injection/84 days 1 implant/year 2 vials (1 mg each)/day 1 vial (2 mg each)/day 2 syringes/year 2 ampules/day 4 bottles/28 days Updated 07/01/2016 Page 2 of 6

Immunology Hematopoietic Agents Hepatitis C Agents Immune Globulins Immunomodulators Interleukins Multiple Sclerosis ARANESP (darbepoetin alfa) EPOGEN (epoetin alfa) LEUKINE (sargramostim) MOZOBIL (plerixafor) NEULASTA (pegfilgrastim) NEUMEGA (oprelvekin) NEUPOGEN (filgrastim) NPLATE (romiplostim) PROCRIT (epoetin alfa) PROMACTA (eltrombopag) SOLIRIS (eculizumab) DAKLINZA (daclatasvir dihydrochloride) DAKLINZA (daclatasvir dihydrochloride) 30 mg HARVONI (ledipasvir-sofosbuvir) PEGASYS (peginterferon alfa-2a) PEG-INTRON (peginterferon alfa-2b) SOVALDI (sofosbuvir) ZEPATIER (elbasvir-grazoprevir) BIVIGAM (immune globulin) CARIMUNE (immune globulin) CYTOGAM (cytomegalovirus immune globulin) FLEBOGAMMA (immune globulin) FLEBOGAMMA DIF (immune globulin) GAMASTAN (immune globulin) GAMMAGARD (immune globulin) GAMMAKED (immune globulin) GAMMAPLEX (immune globulin) GAMUNEX (immune globulin) GAMUNEX-C (immune globulin) HIZENTRA (immune globulin) OCTAGAM (immune globulin) PRIVIGEN (immune globulin) CIMZIA (certolizumab) ENBREL (etanercept) HUMIRA (adalimumab) KINERET (anakinra) ORENCIA (abatacept) REMICADE (infliximab) SIMPONI (golimumab) SIMPONI ARIA (golimumab) ARCALYST (rilonacept) ILARIS (canakinumab) BENLYSTA (belimumab) AMPYRA (dalfampridine) AUBAGIO (teriflunomide) AVONEX (interferon beta-1a) BETASERON (interferon beta-1b) COPAXONE (glatiramer) 8 vials (9.6 ml) per transplant 3 tabs/day 2 vials/4 weeks 1 kit (4 syringes)/28 days 1 package/28 days 1 kit/30 days Updated 07/01/2016 Page 3 of 6

Immunology Multiple Sclerosis Transplant Collagenase Diagnostic Movement Disorder Agents Toxicology Viscosupplements Obstetrics & Gynecology GILENYA (fingolimod) GLATOPA (glatiramer) SOSY 20 mg/ml LEMTRADA (alemtuzumab) NOVANTRONE (mitoxantrone) REBIF (interferon beta-1a) REBIF (interferon beta-1a) Starter Pack TECFIDERA (dimethyl fumarate) TECFIDERA (dimethyl fumarate) Starter Pack TYSABRI (natalizumab) NULOJIX (belatacept) ZORTRESS (everolimus) XIAFLEX (collagenase clostridium histolyticum) THYROGEN (thyrotropin alfa) XENAZINE (tetrabenazine) EXJADE (deferasirox) FERRIPROX (deferiprone) Tabs JADENU (deferasirox) MONOVISC (hyaluronan) ORTHOVISC (sodium hyaluronate) SYNVISC (sodium hyaluronate) SYNVISC-ONE (sodium hyaluronate) Hormone Replacement MAKENA (hydroxyprogesterone caproate) Oncology (Injectable) Antimicrotubular Interferons Kinase and Molecular Target Inhibitors Monoclonal Antibody HALAVEN (eribulin) JEVTANA (cabazitaxel) INTRON A (interferon alfa-2b) SYLATRON (peginterferon alfa-2b) KYPROLIS (carfilzomib) PORTRAZZA (necitumumab) Soln VELCADE (bortezomib) ZALTRAP (ziv-aflibercept) DACOGEN (decitabine) ISTODAX (romidepsin) SYNRIBO (omacetaxine) ADCETRIS (brentuximab) ARZERRA (ofatumumab) BLINCYTO (blinatumomab) DARZALEX (daratumumab) Soln EMPLICITI (elotuzumab) Solr GAZYVA (obinutuzumab) HERCEPTIN (trastuzumab) KADCYLA (ado-trastuzumab emtansine) OPDIVO (nivolumab) 1 cap/day 1 kit/30 days 12 syringes/28 days 1 starter pack/year 2 caps/day 1 starter pack/year 1 injection /28 days 2 vials/21 days Updated 07/01/2016 Page 4 of 6

Oncology (Injectable) PERJETA (pertuzumab) RITUXAN (rituximab) XGEVA (denosumab) YERVOY (ipilimumab) Oncology (Oral) Alkylating Agents Antiandrogen Kinase and Molecular Target Inhibitors TEMODAR (temozolomide) XTANDI (enzalutamide ) ZYTIGA (abiraterone) AFINITOR (everolimus) AFINITOR DISPERZ (everolimus) BOSULIF (bosutinib) CAPRELSA (vandetanib) 100 mg CAPRELSA (vandetanib) 300 mg COMETRIQ (carbozantinib) COTELLIC (cobimetnib) 63 tabs/28 days ERIVEDGE (vismodegib) FARYDAK (panobinostat) 6 caps/ 21 days GILOTRIF (afatinib) GLEEVEC (imatinib) IBRANCE (palbociclib) ICLUSIG (ponatinib) 15 mg ICLUSIG (ponatinib) 45 mg IMBRUVICA (ibrutinib) INLYTA (axitinib) JAKAFI (ruxolitinib) JAKAFI (ruxolitinib) 10 mg LENVIMA (lenvatinib) LYNPARZA (olaparib) MEKINIST (trametinib) NEXAVAR (sorafenib) NINLARO (ixazomib) SPRYCEL (dasatinib) 3 caps/28 days STIVARGA (regorafenib) SUTENT (sunitinib) TAFINLAR (dabrafenib) TAGRISSO (osimertinib) TARCEVA (erlotinib) TASIGNA (nilotinib) 3 tabs/day TYKERB (lapatinib) VOTRIENT (pazopanib) XALKORI (crizotinib) ZELBORAF (vemurafenib) ZYDELIG (idelalisib) ZYKADIA (ceritinib) LONSURF (trifluridine-tipiracil) 15-6.14 MG 100 tabs/28 days Updated 07/01/2016 Page 5 of 6

Oncology (Oral) LONSURF (trifluridine-tipiracil) 20-8.19 MG TARGRETIN (bexarotene) caps 80 tabs/28 days TARGRETIN (bexarotene) Gel XELODA (capecitabine) ZOLINZA (vorinostat) Thalidomide-related Agents POMALYST (pomalidomide) REVLIMID (lenalidomide) THALOMID (thalidomide) Respiratory Asthma/COPD NUCALA (mepolizumab) 1 vial/28 days XOLAIR (omalizumab) Cystic fibrosis CAYSTON (aztreonam) KALYDECO (ivacaftor) KALYDECO (ivacaftor) Packs PULMOZYME (dornase alfa) Pulmonary Fibrosis ESBRIET (pirfenidone) OFEV (nintedanib) Respiratory Syncytial Virus Agents SYNAGIS (palivizumab) Quantity Limit Programs Therapeutic Category Drug Name Dispensing Limit Anti-infectives Antiretrovirals, Hepatitis B Antiretrovirals, HIV Cardiology BARACLUDE (entecavir) BARACLUDE (entecavir) Soln FUZEON (enfuvirtide) 630 ml/30days 60 vials or 1 kit/30 days Anticoagulants, LMWH ARIXTRA (fondaparinux) 35 days supply/180 days Endocrinology & Metabolism Gonadotropins Vasopressin Antagonist Obstetrics & Gynecology FRAGMIN (dalteparin) LOVENOX (enoxaparin) ZOLADEX (goserelin) 10.8 mg ZOLADEX (goserelin) 3.6 mg SAMSCA (tolvaptan) 35 days supply/180 days 35 days supply/180 days 1 injection/84 days 1 injection/28 days 30 days supply/60 days Hormone Replacement CRINONE (progesterone) 8% 60 applicators/30 days Respiratory Cystic fibrosis TOBI PODHALER (tobramycin) 1 package (224 tabs)/56 days PLEASE NOTE: This drug list is subject to periodic updates and may not be all inclusive. Drugs affected include both brand and generic where applicable and includes all dosage formulations unless otherwise specifically notated. If a new drug is approved and falls into one of the targeted PA categories, the new drug may automatically be added to this list. Quantity limits may also apply. *Quantity limits are built into the PA criteria approval and varies based on indication and/or other clinical factors. Updated 07/01/2016 Page 6 of 6

Specialty Pharmacy Drug List - Medical Code Drug Name Generic Name Benefit J9264 Abraxane paclitaxel Medical J3262 Actemra/tocilizumab Anti-inflammatory Medical C9287 Adcetris brentuximab vedotin Medical J1931 ALDURAZYME/laronidase Enzymes Medical J9305 Alimta pemetrexed Medical J2469 Aloxi palonosetron Medical J0256 Aralast* Alpha-1 Medical J9035 Avastin bevacizumab Medical J1556 BIVIGAM IVIG/immunizing Medical J0585 Botox A onabotulinum toxin toxin A Medical J0586 Botox A (Dysport) abobotulinum toxin A Medical J0588 Botox A (Xeomin) incobotulinum toxin A Medical J0587 Botox B (Myobloc) rimabotulinum toxin B Medical J1566 CARIMUNE IVIG/immunizing Medical J0205 CEREDASE/alglucerase Enzymes Medical J1786 CEREZYME/imiglucerase Enzymes Medical J1743 ELAPRASE/idursulfase Enzymes Medical J9055 Erbitux cetuximab Medical J7323 Euflexxa Medical J0180 FABRAZYME/agalsidase Enzymes Medical

J1572 FLEBOGAMMA IVIG/immunizing Medical J0641 Fusilev levoleucovorin Medical J1460 GAMASTAN S/D IVIG/immunizing Medical J1569 GAMMAGARD LIQUID IVIG/immunizing Medical J1566 GAMMAGARD S/D IVIG/immunizing Medical J1561 GAMMAKED IVIG/immunizing Medical J1557 GAMMAPLEX IVIG/immunizing Medical J1561 GAMUNEX IVIG/immunizing Medical J1561 GAMUNEX C IVIG/immunizing Medical J7326 Gel One Medical J0256 Glassia* Alpha-1 Medical J9179 Halaven eribulin mesylate Medical J9355 Herceptin trastuzumab Medical J1559 HIZENTRA IVIG/immunizing Medical J0800 HP Acthar repository corticotropin Medical J7321 Hyalgan Medical J9043 Jevtana cabazitaxel Medical J9354 Kadcyla adotrastuzumab Medical J0221 LUMIZYME/alglucosidase Enzymes Medical J0220 MYOZYME//aglucosiderase Enzymes Medical J1458 NAGLAZYME/galsulfase Enzymes Medical J1568 OCTAGAM IVIG/immunizing Medical J0129 Orencia/abatacept Anti-inflammatory Medical J7324 Orthovisc Medical C9292 Perjeta pertuzumab Medical J1459 PRIVIGEN IVIG/immunizing Medical Q2043 Provenge sipuleucel-t Medical J1745 Remicade/infliximab Anti-inflammatory Medical J9310 Rituxan rituximab Medical J1602 Simponi/golimumab Anti-inflammatory Medical J3357 Stelara/ustekinumab Anti-inflammatory Medical

J7321 Supartz Medical J7325 Synvisc One Medical J7325 Synvisc/Hylan Medical J2323 Tysabri Anti-inflammatory Medical J9303 Vectibix Panitumumab Medical J1562 Vivaglobin Medical J3385 VPRIV/Velaglucerase Alfa Enzymes Medical J2357 Xolair omalizumab Medical J9228 Yervoy ipilimumab Medical J0256 Zemaira*/alpha 1 proteinase Alpha-1 Medical